BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Pharm Country

  Integra LifeSciences To Host Investor Day On May 4, 2023

  Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will host an Investor Day meeting from 8:30 a.m. to approximately 12:00 p.m., U.S. eastern time on May 4, 2023 in New York, NY.

  May 3, 2023

   · 

  1 min read
• Business

  Ionis reports first quarter 2023 financial results

  Ionis Pharmaceuticals, Inc. today reported financial results for the first quarter of 2023.

  May 3, 2023

   · 

  12 min read
• Business

  Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update

  Corcept Therapeutics Incorporated (NASDAQ: CORT) today reported its results for the quarter ended March 31, 2023.

  May 3, 2023

   · 

  10 min read
• Biotech Bay

  Vir Biotechnology to Participate in the BofA Securities 2023 Health Care Conference

  Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer, is scheduled to present at the BofA Securities 2023 Health Care Conference on Wednesday, May 10, at 8:00 a.m. PT / 11:00 a.m. ET.

  May 3, 2023

   · 

  1 min read
• Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2023

  Avadel Pharmaceuticals plc announced that the Compensation Committee of Avadel’s Board of Directors approved the grant of non-statutory options to twenty one new employees to purchase an aggregate of 193,000 ordinary shares under Avadel’s 2021 Inducement Plan.

  May 3, 2023

   · 

  1 min read
• Business

  Fate Therapeutics Reports First Quarter 2023 Financial Results and Business Updates

  Fate Therapeutics, Inc. (NASDAQ: FATE) today reported business highlights and financial results for the first quarter ended March 31, 2023.

  May 3, 2023

   · 

  18 min read
• Biotech Bay

  Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - May 03, 2023

  Terns Pharmaceuticals, Inc. announced that it has granted as of May 1, 2023 equity inducement awards to seven new employees under the terms of the 2022 Employment Inducement Award Plan.

  May 3, 2023

   · 

  1 min read
• Business

  Myriad Genetics Reports First Quarter 2023 Financial Results; Achieves 10% Revenue Growth Year-Over-Year, the Second Consecutive Quarter of Double-Digit Year-Over-Year Revenue Growth; Raises Mid-Point of 2023 Revenue Guidance Range

  Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced financial results for its first quarter ended March 31, 2023.

  May 3, 2023

   · 

  23 min read
• Business

  QIAGEN exceeds outlook for Q1 2023 with 12% CER sales growth in non-COVID product portfolio

  Net sales for Q1 2023 declined 23% to $485 million from Q1 2022, which was marked by very strong COVID-19 sales contributions.

  May 3, 2023

   · 

  7 min read
• Business

  OPKO Health Reports First Quarter 2023 Business Highlights and Financial ResultsConference call begins at 4:30 p.m. Eastern time today

  OPKO Health, Inc. reports business highlights and financial results for the three months ended March 31, 2023.

  May 3, 2023

   · 

  9 min read